Rocket Lab Corporation (NASDAQ:RKLB – Get Free Report) rose 4.9% during mid-day trading on Friday. The stock traded as high as $76.09 and last traded at $73.92. Approximately 26,658,156 shares were traded during mid-day trading, an increase of 15% from the average daily volume of 23,093,289 shares. The stock had previously closed at $70.46.
Rocket Lab News Summary
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Record Synspective contract: Rocket Lab signed its largest-ever commercial Electron agreement—20 dedicated launches scheduled from 2028 through 2031. The deal brings Synspective’s total planned missions to 47 and supports the customer’s StriX satellite constellation. Financial terms were not disclosed, but the contract strengthens long-term revenue visibility and lifts Rocket Lab’s backlog above 100 missions. Rocket Lab’s 20-Launch Synspective Deal Pushes Backlog Above 100 Missions
- Positive Sentiment: Fresh analyst support: Citi initiated coverage with a Buy rating and a $105 price target, describing Rocket Lab as a core holding for space-focused investors. Other analyst targets cited in recent coverage imply additional upside, reinforcing the market’s view that Electron demand and the upcoming Neutron rocket could support substantial growth. Citi Calls Rocket Lab a Core Holding for Space Bulls
- Positive Sentiment: ARK Invest accumulation: Cathie Wood’s ARK ETFs reportedly purchased more than $41 million of RKLB shares recently, including 233,482 shares across ARKK, ARKQ, and ARKX. The buying signals continued institutional confidence in Rocket Lab’s launch business and Neutron opportunity. Cathie Wood Is Buying Rocket Lab Again
- Neutral Sentiment: Broader space-sector momentum: Recent launch activity by SpaceX helped lift investor interest across rocket and launch companies, adding to the sector’s positive trading backdrop. Rocket Lab’s revenue also grew nearly 62% year over year to approximately $234 million in the latest quarter, though it remains unprofitable.
- Negative Sentiment: Competition and execution risks: SpaceX’s Starship reaching orbit could pressure launch economics and pricing for smaller providers. Rocket Lab must also execute the long-term Electron schedule and successfully develop Neutron to justify its elevated valuation. In addition, reported insider activity shows substantial selling and no open-market purchases among listed insiders over the past six months.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on RKLB shares. Wall Street Zen lowered Rocket Lab from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Citigroup began coverage on Rocket Lab in a research note on Thursday. They issued a “buy” rating and a $105.00 price objective on the stock. Cantor Fitzgerald reiterated an “overweight” rating on shares of Rocket Lab in a report on Monday, September 21st. Craig Hallum increased their target price on shares of Rocket Lab from $98.00 to $120.00 and gave the company a “buy” rating in a research report on Monday, June 29th. Finally, Stifel Nicolaus set a $132.00 price target on shares of Rocket Lab in a report on Thursday, June 4th. Four research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $107.20.
Rocket Lab Stock Performance
The company has a market cap of $44.23 billion, a PE ratio of -273.77 and a beta of 2.93. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average of $69.57 and a 200-day moving average of $84.41.
Rocket Lab (NASDAQ:RKLB – Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The company had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. As a group, analysts anticipate that Rocket Lab Corporation will post -0.2 earnings per share for the current year.
Insider Transactions at Rocket Lab
In related news, SVP Arjun Kampani sold 6,034 shares of Rocket Lab stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $66.65, for a total transaction of $402,166.10. Following the sale, the senior vice president directly owned 250,917 shares in the company, valued at approximately $16,723,618.05. This trade represents a 2.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Agostino Ricupati sold 669 shares of Rocket Lab stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $46,582.47. Following the sale, the chief accounting officer owned 26,863 shares in the company, valued at $1,870,470.69. The trade was a 2.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 3,536,371 shares of company stock worth $303,442,641. Company insiders own 8.40% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. bought a new stake in Rocket Lab in the 2nd quarter valued at about $4,124,970,000. Bank of New York Mellon Corp bought a new position in shares of Rocket Lab in the second quarter worth $245,764,000. Bank of America Corp DE purchased a new position in Rocket Lab during the 2nd quarter valued at about $437,280,000. Capital World Investors increased its holdings in Rocket Lab by 12.0% during the 4th quarter. Capital World Investors now owns 16,200,726 shares of the rocket manufacturer’s stock worth $1,130,172,000 after acquiring an additional 1,738,623 shares during the period. Finally, Legal & General Group Plc bought a new position in shares of Rocket Lab in the second quarter worth $171,763,000. 71.78% of the stock is owned by institutional investors.
About Rocket Lab
Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.
Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.
Further Reading
- Five stocks we like better than Rocket Lab
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.
